Volume 12 Supplement 1

17th International Confernce on Human Retroviruses: HTLV and Related Viruses

Open Access

ORFI genetic polymorphisms in geographically distinct HTLV-1 infections

  • Fernanda Khouri Barreto1, 2Email author,
  • Ricardo Khouri1,
  • Filipe Ferreira de Almeida Rego1,
  • Maria Fernanda de Castro-Amarante3,
  • Izabela Bialuk4,
  • Cynthia A Pise-Masison3,
  • Bernardo Galvão-Castro1, 2,
  • Antoine Gessain5,
  • Steven Jacobson6,
  • Genoveffa Franchini3 and
  • Luiz Carlos AlcantaraJr1
Retrovirology201512(Suppl 1):P55

https://doi.org/10.1186/1742-4690-12-S1-P55

Published: 28 August 2015

The region known as pX in the 3’ end of the human T-cell leukemia/lymphoma virus type-1 (HTLV-1) genome contains four overlapping open reading frames (ORF) that encode regulatory proteins. The expression of ORF-I produces the protein p12 which can be cleavage resulting in the p8 protein. These proteins interfere with the ability of a biologically active of HTLV-1, influencing at the virus infectivity and persistence. Here, we evaluated whether natural mutations in HTLV-1 ORF-I can influence the proviral load and clinical manifestation of HAM/TSP. For that, we analyzed 1530 HTLV-1 ORF-I sequences from different clones of 156 patients with negative or positive diagnosis for HAM/TSP and demonstrated that some mutations may be associated with the outcome of HAM/TSP (C39R, L40F, P45L, S69G and R88K) or with proviral load (P34L and F61L). We further examined the presence of mutations in motifs of HBZ and observed that P45L mutation is located within the HBZ nuclear localization signal and was found more frequently between patients with HAM/TSP and high proviral load. This results suggest that some HTLV-1 ORF-I mutations may be associated with the development of HAM/TSP and the proviral load levels.

Authors’ Affiliations

(1)
Centro de Pesquisa Gonçalo Moniz-Fiocruz
(2)
Escola Bahiana de Medicina e Saúde Pública
(3)
Animal Models and Retroviral Vaccines Section, National Cancer Institute
(4)
Department of General and Experimental Pathology, Medical University of Białystok
(5)
Unité d'Epidémiologie et Physiopathologie des Virus Oncogènes, Département de Virologie, Batiment Lwoff, Institut Pasteur
(6)
Viral Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke

Copyright

© Barreto et al. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement